Dr. John Cush RheumNow
9 months 2 weeks ago
Reefer Madness (12.12.2025)
Dr. Jack Cush reviews the news, journal and regulatory reports from this past week on RheumNow. B cell drugs in SLE and ITP, biomarkers in GCA & PSS and great videos by APPs.
https://t.co/SKEYlhTfLz https://t.co/mBX4GIQxKe
Dr. John Cush RheumNow
9 months 2 weeks ago
Evaluation of Rheumatic Complaints
https://t.co/cdizOgFqYf https://t.co/sqbrY2oGcH
New findings from national U.S. surveys reveal the profound impact of arthritis on millions of adults, especially those facing social and economic challenges. These data will be featured in an upcoming issue of Arthritis Care & Research, an official journal of the American College of Rheumatology.
In 2023, a EULAR subcommittee set out to assess the roles of nurses and Advanced Practice Nurses (APN) in the care of arthritis as outlined in published EULAR guidelines. The scope of APN practices was first proposed in 2012 and revised in 2018. EULAR updated its recommendations for the role of the nurse in the management and care of patients with rheumatic conditions.
Dr. John Cush RheumNow
9 months 2 weeks ago
RheumaKnowledgy Card
https://t.co/ZPTmT8kgDX https://t.co/E3IREKimx6
Dr. Jack Cush reviews autoantibody testing in rheumatology.
Dr. John Cush RheumNow
9 months 2 weeks ago
AANP survey of US 2338 Nurse Practitioners (mostly primary care) re: shared pts w/ rheumatologists. NPs managing RA want improved communication w/ rheums, & education on RA management. PC NP confidence w/ RA was 47% Somewhat confident, 6% very confident, 19% not confident. https://t.co/YVEpJua9hj
Dr. John Cush RheumNow
9 months 2 weeks ago
Top 10 States to Practice Rheumatology
1 North Dakota
2 Wisconsin
3 Alaska
4 Montana
5 South Dakota
6 Nebraska
7 Minnesota
8 Washington
9 Utah
10 Maine https://t.co/x2tKflV2S7 https://t.co/fLMEhQV0js
Dr. John Cush RheumNow
9 months 2 weeks ago
Tarsal Tunnel Syndrome - review and quiz.
A compressive neuropathy of the posterior tibial nerve within the tarsal tunnel. 80% caused by lipoma, ganglion, varicosity, trauma, tenosynovitis, rheumatoid arthritis, diabetes, etc https://t.co/zCyeVIJEuy https://t.co/f4jA13FDvN
Dr. John Cush RheumNow
9 months 2 weeks ago
In US, Tofacitinib loses patent exclusivity & goes generic in 2026. Worldwide Tofa sales in 2024 were $3.08 billion (55% use in RA; N. America 1st w/ ~38% of market). Tofa sales projected to rise to $5.7 bill in 2029 https://t.co/nKPaQdglYw https://t.co/DdMymmk8go
A large observational cohort study suggests that monitoring hydroxychloroquine (HCQ) blood levels is effective in systemic lupus erythematosus (SLE) patients with a target therapeutic range (for HCQ level monitoring) of 750-1150 ng/ml.
Dr. John Cush RheumNow
9 months 2 weeks ago
Israeli retrospective study of 9736 colchicine Rx FMF pts matched w/ 97 360 controls. On F/U Psoriatic arthritis developed in more FMF pts (43 vs 119) - HR 3.52 (CI: 2.48, 5.0). ^Risk w/ older age, smoking, SES https://t.co/blDIsmHWPC
Dr. John Cush RheumNow
9 months 2 weeks ago
Survey of physician assistants finds 56% use AI daily (19% AI extensively). 87% PAs say they need to learn more about AI, 83% desire formal, employer-led AI training. 89% believe AI will dramatically changes PA practice, but only 32% have clear workplace guidelines on AI usage https://t.co/yGqZRC3mNt
